A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS

Clinical trial NCT00837785 · COMPLETED

Trial details

NCT number: NCT00837785
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2009-02-28
Primary completion: 2009-10-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.